264
Participants
Start Date
June 18, 2015
Primary Completion Date
February 16, 2016
Study Completion Date
February 16, 2016
SHP465
12.5mg and 25mg capsules (one capsule daily)
Placebo
Matching placebo capsule that appear identical in size, weight, shape, color
Coastal Carolina Research Center, Mt. Pleasant
Rainbow Research, Barnwell
Northwest Behavioral Research Center, Marietta
Clinical Neuroscience Solutions, Inc., Jacksonville
Sarkis Clinical Trials, Gainesville
Medical Research Group of Central Florida, Orange City
Clinical Neuroscience Solutions, Inc., Orlando
Miami Research Associates, Llc, South Miami
Janus Center For Psychiatric Research, West Palm Beach
Florida Clinical Research Center, Llc, Bradenton
Harmonex Neuroscience Research, Dothan
Clinical Neuroscience Solution, Inc, Memphis
Midwest Clinical Research Center, Dayton
Rochester Center For Behavioral Medicine, Rochester Hills
Capstone Clinical Research, Libertyville
Baber Research Group Inc, Naperville
Midwest Research Group, Saint Charles
Psychiatric Care and Research Center, O'Fallon
Psychiatric Associates, Overland Park
Louisiana Research Associates, Inc, New Orleans
Tulsa Clinical Research, Llc, Tulsa
Research Across America, Plano
Futuresearch Trials of Dallas, Lp, Dallas
Bayou City Research, Houston
Red Oak Psychiatry Associates, Pa, Houston
Houston Clinical Trials, Llc, Houston
Westex Clinical Investigations, Lubbock
McB Clinical Research Centers, Colorado Springs
Center For Psychiatry and Behavioral Medicine, Las Vegas
Encompass Clinical Research, Spring Valley
Pcsd Feighner Research, San Diego
Elite Clinical Trials, Inc, Wildomar
Nrc Research Institute, Orange
Oregon Center For Clinical Investigations, Inc, Salem
Eastside Therapeutic Resource, Kirkland
Omega Medical Research, Warwick
Lead Sponsor
Shire
INDUSTRY